New experimental treatment could cut cholesterol levels in half, early research suggests

  • Good news: Former NFL player's passion for woodworking attracts an audience of millions

    01:56

  • Millions on edge over winter blast as cold snap sweeps US

    01:18

  • Travel nightmare worsens as FAA cuts lead to thousands of flight disruptions

    02:12

  • Exclusive: How Netflix is ​​tapping into Gen Z's mall resurgence

    02:15

  • Currently playing

    New experimental treatment could halve cholesterol levels, early study suggests

    01:41

  • NEXT

    The royal family appeared together amid the dispute between Andrew and Epstein

    01:44

  • Two Cleveland Guardians players charged with rigging fields in betting scheme

    01:38

  • A new agreement has emerged on Capitol Hill that could end the government shutdown.

    02:15

  • Good news: longtime pen pals met for the first time

    03:07

  • Thousands of flights delayed as FAA cuts operations at major airports

    02:10

  • Inside the Battle to Fund Addiction Research

    02:25

  • Ground fleets of UPS and FedEx aircraft of the same MD-11 type involved in the Louisville crash

    01:29

  • Ghislaine Maxwell's prison emails show she's 'happier' in a Texas minimum security prison

    01:45

  • Federal immigration agents were shot at in Chicago, the Department of Homeland Security says.

    02:10

  • Supreme Court allows Trump administration to suspend some food benefits

    02:03

  • Hundreds of flights canceled as FAA cuts take effect

    02:06

  • Colombia continues anti-drug operations despite US criticism

    01:29

  • Yoko Ono's “Wishing Tree” in full bloom

    01:47

  • Former NFL star Mark Sanchez on Fox Sports

    01:35

  • Housekeeper dies in shootout after arriving at the wrong house

    01:33

Weekend

A new experimental treatment involving gene therapy can cut cholesterol levels in half in some people, according to new research presented Saturday at the annual meeting of the American Heart Association. NBC News' Erica Edwards has more.

Leave a Comment